Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
07/2003
07/24/2003US20030138931 Hydrolase polypeptide for dephosphorylating mitogen activated kinases (MAP-kinase); antiapoptosis; antiproliferative agents
07/24/2003US20030138926 Novel polynucleotides and polypeptides encoded thereby
07/24/2003US20030138915 Apotosis-2 ligand receptor/tumor necrosis factor for detecting modulator of apoptosis; drug screening; treating nervous system and liver disorders; antiproliferative agents
07/24/2003US20030138899 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138893 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138892 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138891 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138889 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138888 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138887 For release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
07/24/2003US20030138886 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138885 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138884 APRIL- a novel protein with growth effects
07/24/2003US20030138883 For release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
07/24/2003US20030138882 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138862 Anti-HLA-DR antibodies and the methods of using thereof
07/24/2003US20030138859 Assay kits and methods for immune complex-mediate activation involving shed antigens
07/24/2003US20030138857 Screening for modulators of macrophage colony-stimulating factor induced killing of smooth muscle cells; diagnosing cardiovascular disorders; anticoagulants
07/24/2003US20030138844 Antibodies binding a gamma carboxyglutamic acid displaying epitope
07/24/2003US20030138839 Polypeptide comprising ubiquitination regulating domain; antiproliferative agents; neuroprotectants; cancer diagnosis
07/24/2003US20030138836 Detecting modulators of a silencing mediator for retinoic acid receptor; relieving suppression of steroid/thyroid hormone receptor activity; GAL4 DNA binding domains
07/24/2003US20030138820 Sugar transport protein for use in diagnosis and treatment of diabetes, hypertriglyceridemia and hyperinsulinemia
07/24/2003US20030138818 G-protein coupled receptors
07/24/2003US20030138815 Cyclic adenosine monophosphate (cAMP); drug screening; bronchodilators; antiinflammatory agents; immunomodulators; antiallergens; bioassays
07/24/2003US20030138807 Nucleotide sequences coding polypeptide associated with biosynthesis of glycans found as free oligosaccharides or bound to glycosphingolipids; treatment and prevention of infections; gene therapy; antiproliferative agents
07/24/2003US20030138804 Hemagglutinin binding protein; antiallergens; antinflammatory; neuroprotectants; wound healing agents
07/24/2003US20030138447 Derivatives of choline binding proteins for vaccines
07/24/2003US20030138442 Protein- or polynucleic acid-based vaccine which protects a pig against porcine reporductive and respiratory syndrome
07/24/2003US20030138440 Multimeric proteins and methods of making and using same
07/24/2003US20030138438 Compositions and methods for the therapy and diagnosis of lung cancer
07/24/2003US20030138434 Containing an immunogen, a first adjuvant functioning as a directing molecule and a second adjuvant functioning as a stimulant which are chemically distinct
07/24/2003US20030138429 Compositions and methods for inhibiting metastasis
07/24/2003US20030138428 In vitro and in vivo diagnosis, immunization, and therapy of neoplastic tumors, particularly carcinomas, by means of specifically targeted analogue peptides containing amino acid sequences encompassing CDRs of different species
07/24/2003US20030138425 An antibody that preferentially binds to the same epitope on cytokeratin 8 as antibody mhoe-4 preferentially binds; linked to a therapeutic agent,e.g., saporin; kits; antiproliferation agents; immunotherapy; diagnosis/medical
07/24/2003US20030138424 An antibody capable of inhibiting the binding between parathyroid hormone related protein (PTHrP) and a receptor; antagonists; systemic disorders caused by cancer; anorexic agents; anemia, electrolyte imbalance; immunotherapy
07/24/2003US20030138422 Antibodies against growth and differentiation factor-8 (GDF-8), also known as myostatin, including fragments; muscle and bone degenerative disorders; muscular dystropy/atrophy; antidiabetic agents; congestive obstructive pulmonary disease
07/24/2003US20030138421 Human Antibodies specific for interleukin 15 (IL-15)
07/24/2003US20030138420 Administering a tissue factor, e.g., a monoclonal antibody, a human tissue factor binding site polypeptide analog of <50 amino acid residues, by injection into the tissue of the central nervous system, brain and myocardium; anticoagulants
07/24/2003US20030138419 Recombinant antibody fusion proteins and methods for detection of apoptotic cells
07/24/2003US20030138417 Comprising a succinate of histadine buffer having pH from 5.5-6.5, polysorbate, and a tonicity modifier to contribute to the isotonicity, e.g., NaCl or MgCl2; storage stability of 1-2 years; antiagglomerants
07/24/2003US20030138404 Interferon antagonists useful for the treatment of interferon related diseases
07/24/2003US20030138400 Polypeptides that are truncated forms of human chemokine beta-8
07/24/2003US20030138377 Use of metabolic phenotyping in individualized treatment with amonafide
07/24/2003CA2513013A1 Use of soluble .gamma..delta. t cell receptors for regulating t cell function
07/24/2003CA2477348A1 Nucleic acids encoding a g-protein coupled receptor involved in islet cell signaling
07/24/2003CA2474151A1 Androgen regulated nucleic acid molecules and encoded proteins
07/24/2003CA2474002A1 Bispecific antibody dna constructs for intramuscular administration
07/24/2003CA2473039A1 Novel anti-igf-ir antibodies and uses thereof
07/24/2003CA2472579A1 Hiv vaccine and method of use
07/24/2003CA2471907A1 Antibody-avidin fusion proteins as cytotoxic drugs
07/24/2003CA2471702A1 Human monoclonal antibodies against cd30
07/24/2003CA2471480A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
07/24/2003CA2470998A1 Anti-angiogenic proteins and fragments and methods of use thereof
07/24/2003CA2470421A1 Use of a novel cell surface protease from group b streptococcus
07/24/2003CA2469715A1 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
07/24/2003CA2464472A1 Antibody targeting compounds
07/24/2003CA2463008A1 Efficient protein expression system
07/23/2003EP1329511A1 Polypeptide having phospholipase a2 actiivty
07/23/2003EP1329507A1 Artificial protein having potentiated immunogenicity of epitope
07/23/2003EP1329503A1 Sphingolipid ceramide deacylase gene
07/23/2003EP1329459A2 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon
07/23/2003EP1328812A2 Method for quantifying phosphokinase activity on proteins
07/23/2003EP1328661A2 Estrogen receptor alpha variants and methods of detection thereof
07/23/2003EP1328656A1 Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents
07/23/2003EP1328647A1 Isomaltulose synthase
07/23/2003EP1328635A2 Compositions and methods relating to lung specific genes
07/23/2003EP1328634A2 Genes expressed in the cell cycle
07/23/2003EP1328630A2 Secreted proteins
07/23/2003EP1328629A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
07/23/2003EP1328626A1 Single-domain brain-targeting antibody fragments derived from llama antibodies
07/23/2003EP1328625A2 Dermatophagoides nucleic acid molecules, proteins and uses thereof
07/23/2003EP1328624A2 B7-like molecules and uses thereof
07/23/2003EP1328619A1 Human tuberoinfundibular peptide of 39 residues
07/23/2003EP1328549A1 Human prostate specific g-protein receptor hpraj70
07/23/2003EP1328548A2 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
07/23/2003EP1328547A1 Identification and modification of immunodominant epitopes in polypeptides
07/23/2003EP1328545A1 Human gene critical to fertility
07/23/2003EP1328542A1 Von willebrand factor-binding proteins from staphylococci
07/23/2003EP1328541A2 Basb207 polypeptides and polynucleotides from nontypeable haemophilus influenzae
07/23/2003EP1328298A1 Methods and compositions for modulating t cell activation and uses thereof
07/23/2003EP1328293A2 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
07/23/2003EP1328289A2 Oxidized proteins, their biological activity, and therapeutic and diagnostic measures, which are derived from the active mechanism, from the use of these proteins or from the inhibition thereof
07/23/2003EP1328287A1 Compositions and methods for wt1 specific immunotherapy
07/23/2003EP1328151A2 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
07/23/2003EP1042459A4 Bifunctional molecules
07/23/2003EP0814827B1 Vascular endothelial growth factor-b
07/23/2003EP0743958B1 Avidin-biotin immunoconjugates
07/23/2003EP0648226B1 NATURAL HUMAN IgM ANTIBODIES
07/23/2003EP0586607B1 HEREGULINS (HRGs), BINDING PROTEINS OF P185?erb2
07/23/2003CN1432067A Sperm-DNA complexes for genetically modifying non-human animals
07/23/2003CN1432063A Humanised antibodies to epidermal growth factor receptor
07/23/2003CN1432062A Novel protein and gene encoding same
07/23/2003CN1431307A Derivatization growth factor 4 of human liver cancer, its coding sequence, preparing method and usage
07/23/2003CN1431305A Reorganization immunity toxin with high specificity and its preparing method
07/23/2003CN1431224A EJOI coding albumen of gene related to ovary growth of mitten crab
07/23/2003CN1431222A Monoclone antibody of rice blast germ and detection peridium as well as method for locating antigen surface
07/22/2003USRE38202 Antibodies specific for a haemostatic protein, their use for isolating protein, haemostatic compositions devoid of proteolytic cleavage products of the protein
07/22/2003US6596853 Nucleotide sequences coding polypeptide for use in the treatment of cancer and prevention of infections
07/22/2003US6596852 Antibodies that bind the cytokine designated LERK-5
07/22/2003US6596851 Antibody for use in the treatment of cell proliferative disorders
1 ... 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 ... 1494